$0.41
3.04% day before yesterday
Nasdaq, Nov 07, 10:17 pm CET
ISIN
US1897631057
Symbol
CODX

Co-Diagnostics, Inc. Stock price

$0.41
+0.03 8.35% 1M
+0.06 16.03% 6M
-0.34 45.85% YTD
-0.77 65.58% 1Y
-3.17 88.66% 3Y
-11.08 96.47% 5Y
-5.40 93.01% 10Y
-5.40 93.01% 20Y
Nasdaq, Closing price Fri, Nov 07 2025
+0.01 3.04%

Key metrics

Basic
Market capitalization
$24.4m
Enterprise Value
$11.1m
Net debt
positive
Cash
$13.4m
Shares outstanding
36.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
24.4 | 46.7
EV/Sales
11.1 | 21.1
EV/FCF
negative
P/B
0.6
Financial Health
Equity Ratio
84.9%
Return on Equity
-69.3%
ROCE
-90.6%
ROIC
-124.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.0m | $523.3k
EBITDA
$-37.5m | -
EBIT
$-38.8m | $-31.4m
Net Income
$-36.0m | $-27.1m
Free Cash Flow
$-33.2m
Growth (TTM | estimate)
Revenue
-89.1% | -86.7%
EBITDA
-0.1% | -
EBIT
-0.1% | 21.8%
Net Income
4.2% | 28.0%
Free Cash Flow
-26.5%
Margin (TTM | estimate)
Gross
39.6%
EBITDA
-3,733.3% | -
EBIT
-3,860.9%
Net
-3,585.8% | -5,183.7%
Free Cash Flow
-3,311.2%
More
EPS
$-1.1
FCF per Share
$-0.9
Short interest
0.3%
Employees
132
Rev per Employee
$30.0k
Show more

Is Co-Diagnostics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Co-Diagnostics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Co-Diagnostics, Inc. forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a Co-Diagnostics, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Co-Diagnostics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1 1
89% 89%
100%
- Direct Costs 0.61 0.61
83% 83%
61%
0.40 0.40
93% 93%
40%
- Selling and Administrative Expenses 19 19
5% 5%
1,862%
- Research and Development Expense 19 19
17% 17%
1,924%
-37 -37
0% 0%
-3,747%
- Depreciation and Amortization 1.28 1.28
0% 0%
128%
EBIT (Operating Income) EBIT -39 -39
0% 0%
-3,875%
Net Profit -36 -36
4% 4%
-3,599%

In millions USD.

Don't miss a Thing! We will send you all news about Co-Diagnostics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Co-Diagnostics, Inc. Stock News

Neutral
Seeking Alpha
3 days ago
Co-Diagnostics, Inc. ( CODX ) Discusses Saudi Arabia Joint Venture, AI Initiatives and Diagnostics Technology Developments November 5, 2025 11:00 AM EST Company Participants Dwight Egan - Chairman & CEO Conference Call Participants Valter Pinto Presentation Valter Pinto Good morning, and welcome, everyone, to the Co-Diagnostics fireside chat. My name is Valter Pinto.
Neutral
PRNewsWire
4 days ago
SALT LAKE CITY , Nov. 5, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a patented platform for developing advanced molecular diagnostic tests, today announced that it has engaged Maxim Group LLC ("Maxim") as its exclusive financial advisor to assist the Company in identifying potential strategic alternatives for the Com...
Neutral
PRNewsWire
6 days ago
Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx's existing and future AI initiatives SALT LAKE CITY , Nov. 3, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announ...
More Co-Diagnostics, Inc. News

Company Profile

Co-Diagnostics, Inc. engages in the development, manufacture, and marketing of diagnostics technology. It offers design services, vector control, equipment, diagnostic, and research solutions. The company was founded by Brent C. Satterfield and Dwight H. Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Head office United States
CEO Dwight Egan
Employees 132
Founded 2013
Website codiagnostics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today